Revolution Medicines, Inc.
RVMDBiotechnology
$190.27+0.82%As of Oct 29vs prior close
- Market cap
- $40.8B
- P/E (TTM)
- –
- From 52W high
- −13.96%
- EPS (YE25)
- -$5.95
- Revenue (YE25)
- $0
Nomior Score
62
Steady ProfileTop 22% of the scored universe
Growth56
Quality41
Value51
Momentum100
Resilience42
Growth
$0revenue, YE25
YE18 $20.2MYE25 $0
Connections
Revenue to profitQ4 YE23
The operating loss was 24256% of revenue.
Who owns it
1fund, 1 tracked portfolio